9 jul 2018 año - FDA hosted a public meeting on Patient-Focused
Drug Development for chronic pain to hearing
patients’ perspectives on chronic pain, views on
treatment approaches, and challenges or barriers
to accessing treatments for chronic pain.
Añadido al timeline:
Opioids and the FDA
fecha:
